DOCSLIB.ORG

Legal Rights of Children with Epilepsy in School and Child Care – an Advocate’S Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Legal Rights of Children with Epilepsy in School and Child Care – an Advocate’S Manual Legal Rights of Children with Epilepsy in School & Child Care AN ADVOCATE’S MANUAL AN ADVOCATE’S AN ADVOCATE’S MANUAL AN ADVOCATE’S First Edition Legal Rights of Children with Epilepsy in School and Child Care – An Advocate’s Manual First Edition Prepared by Leslie Seid Margolis Managing Attorney Maryland Disability Law Center Edited by Gary Gross Director Jeanne A. Carpenter Epilepsy Legal Defense Fund Epilepsy Foundation of America® User is hereby granted permission to copy or disseminate this publication, either in print or electronic format, provided such copies are not made, distributed or used for commercial purposes, and that the user affixes the Epilepsy Foundation’s copyright notice, and states that copying is by permission of the Epilepsy Foundation. To disseminate otherwise, or to republish, requires written permission from the Epilepsy Foundation. Permission can be obtained by contacting the Foundation’s Legal Department at 301-459-3700. The Epilepsy Foundation does not evaluate, promote or endorse commercial products, and nothing contained in this document is intended to be an endorsement of any particular treatment for seizures or epilepsy. © 2008 Epilepsy Foundation of America, Inc. Epilepsy Foundation® and Epilepsy Foundation of America® are registered trademarks of the Epilepsy Foundation of America, Inc. TABLE OF CONTENTS ACKNOWLEDGEMENTS …………………………………………….xiii ABOUT THE AUTHOR ...........................................................................xiv INTRODUCTION …………………………………………………………1 CHAPTER ONE What Do Attorneys and Advocates Need to Know About Seizures and Epilepsy?........................................................................................................ 5 1.1Q: What is a seizure? ................................................................................................ 5 1.2Q: What is epilepsy?................................................................................................. 5 1.3Q: How common is epilepsy?................................................................................... 5 1.4Q: How is epilepsy classified?.................................................................................. 5 1.5Q: Are there different types of seizures? .................................................................. 6 1.6Q: What are partial seizures?.................................................................................... 6 1.7Q: What are generalized seizures?............................................................................ 7 1.8Q: Are there particular epilepsy syndromes or conditions?...................................... 7 1.9Q: Can seizures be triggered by anything in particular?........................................... 9 1.10Q: What is status epilepticus?................................................................................... 9 1.11Q: How is epilepsy treated?...................................................................................... 9 1.12Q: What are the standard antiepileptic drugs (AEDs)?............................................. 9 1.13Q: What are the side effects of AEDs?................................................................... 10 1.14Q: What is the Ketogenic diet? ................................................................................10 1.15Q: Does the ketogenic diet have side effects or drawbacks?.................................. 11 1.16Q: What is the vagus nerve stimulator (VNS)? ...................................................... 11 1.17Q: Does the VNS have side effects or drawbacks? ................................................ 11 1.18Q: How may epilepsy affect a student? .................................................................. 11 1.19Q: What is the appropriate intervention for a child who has a seizure at school or in a child care setting?........................................................................ 12 1.20Q: What are the practical implications of this information for attorneys and advocates working with children with epilepsy and their families?.................. 13 i CHAPTER TWO What Laws Apply to Children with Epilepsy? ........................................ 14 2.1Q: What are the primary laws that apply to children with epilepsy?...................... 14 2.2Q: What are the major provisions of the IDEA? .................................................... 14 2.3Q: What is a “free appropriate public education?”................................................. 14 2.4Q: Are all children with disabilities entitled to special education services under the IDEA?.......................................................................................................... 15 2.5Q: Since epilepsy is not included as one of the listed disabilities, does that mean students with epilepsy are not protected by the IDEA?..................................... 15 2.6Q: How does a school system decide that a student needs special education? .......15 2.7Q: Does the IDEA impose requirements for the evaluation process? .................... 16 2.8Q: What is an IEP?.................................................................................................. 17 2.9Q: Who develops the IEP?...................................................................................... 17 2.10Q: What are the related services referred to above? ............................................... 18 2.11Q: What does “least restrictive environment” mean?............................................. 18 2.12Q: Does the IEP team have additional responsibilities as it develops the IEP? ..... 18 2.13Q: Can students with disabilities be suspended for disciplinary reasons?.............. 19 2.14Q: Do parents have rights in the special education process?.................................. 20 2.15Q: What rights do parents and students have under the IDEA if English is not their native language? ........................................................................................ 21 2.16Q: What is Section 504 of the Rehabilitation Act of 1973? ................................... 21 2.17Q Who is protected by Section 504? ..................................................................... 21 2.18Q: What is considered a “physical or mental impairment” under Section 504?..... 21 2.19Q: Are all people with epilepsy automatically covered by Section 504? ............... 22 2.20Q: What is a “major life activity” under Section 504? ........................................... 22 2.21Q: What are the requirements of Section 504 for public school systems? ............. 22 2.22Q: Does Section 504 require placement of students in the least restrictive environment? ..................................................................................................... 23 2.23Q: Does Section 504 have requirements about evaluation and placement? ........... 23 ii 2.24Q: Does Section 504 have requirements about physical accessibility of buildings?........................................................................................................... 23 2.25Q: Does Section 504 apply to students with disabilities beyond the age of 21? .... 24 2.26Q: What happens if a school district or other recipient of federal funding violates Section 504?....................................................................................................... 24 2.27Q: What is the Americans with Disabilities Act?................................................... 24 2.28Q: Does the ADA apply to schools? ………………………………………………25 2.29Q: What happens if a school violates the ADA? .................................................... 25 2.30Q: Must parochial schools comply with Section 504 or the ADA ………………..25 CHAPTER THREE What are the Legal Rights of Children with Epilepsy in the Child Care Setting? .................................................................................... 27 3.1Q: Can a child care provider reject a child from care on the basis of the child’s epilepsy? ............................................................................................................ 27 3.2Q: What general obligations do child care providers have under the ADA and Section 504?....................................................................................................... 27 3.3Q: Can a child care provider reject a child with epilepsy from care because the child needs routine administration of antiepileptic drugs (AEDs) to prevent or minimize seizures? ........................................................................................ 28 3.4Q: Can a child care provider reject a child with epilepsy from care because the child would require administration of emergency antiepileptic medication, such as diazepam rectal gel, in the event of a prolonged seizure or cluster of seizures?............................................................................................................. 29 3.5Q: What level of individualized attention must be provided to a child with epilepsy?........................................................................................................... 30 3.6Q: What accommodations must a child care provider make for a child with epilepsy?.................................................................................................... 31 3.7Q: Are all child care providers required to make the same level of accommodations for a child with epilepsy?....................................................... 31 3.8Q: May child care providers charge parents of a child with epilepsy for the cost of needed
Load more

Recommended publications
  • Rectal Administration of Aid-In-Dying Medications
    Rectal Administration of Aid-in-Dying Medications (NOTE: This is a medical procedure and requires a trained clinician who can evaluate the patient for this procedure, do a rectal exam to be sure that the procedure can be safely accomplished, and be responsible for potential complications. We do not recommend that this be done by families alone without significant direct clinician participation.) by Thalia DeWolf, RN, CHPN For questions and/or information, email [email protected] An Essential Warning: Aid-in-dying medications are a thick suspension of powders. They can clog a Macy Catheter. So while Macy Catheters are indeed wonderful and useful devices for end-of- life care, they should not be used for medical aid in dying. See below for proper materials. Pre-care: An intact, empty, warm, moist, well-perfused rectum assures thorough absorption of rectally administered aid-in-dying medications. Be sure your patient has good bowel care in the 72 hours before aid in dying. A daily soft BM is recommended. The best practice is to do an enema the day before or the morning of aid in dying. Within 24 hours of the procedure (or at the time of the procedure) a digital rectal exam must be performed by an experienced clinician (RN or physician) The clinician must ascertain that the lumen is patent and will accept the catheter; that the rectal vault is not filled with stool (small amounts of stool will not interfere with absorption of medications, large amounts, especially of thick, pasty stool, are likely to bind the medications and prevent absorption; that tumor has not invaded the rectum; that the rectum is warm and well-perfused).
    [Show full text]
  • Case Number 2012030517 Modified Document for Accessibility
    BEFORE THE OFFICE OF ADMINISTRATIVE HEARINGS STATE OF CALIFORNIA In the Matter of: PARENT ON BEHALF OF STUDENT, OAH CASE NO. 2012030517 v. LOS ANGELES UNIFIED SCHOOL DISTRICT. DECISION Administrative Law Judge Deborah Myers-Cregar, Office of Administrative Hearings (OAH), State of California, heard this matter on May 29, May 30, and June 1, 2012, in Van Nuys, California. The parties submitted closing briefs on June 11, 2012, at which time the matter was submitted. Student’s mother (Parent) represented Student. Jeffrey Morris, Attorney at Law, represented District. Jacqueline Campos appeared on behalf of District. On March 15, 2012, Student filed a Request for Due Process Hearing (complaint). On April 12, 2012, the parties jointly requested a continuance, which was granted for good cause. ISSUE Whether District denied Student a free and appropriate public education (FAPE) during the 2011-2012 school year by failing to offer an opportunity to be in her stander twice daily. Accessibility modified document FACTUAL FINDINGS 1. As of the time of hearing, Student was 19 years old and under conservatorship of her Parent due to cerebral palsy, severe scoliosis, low cognition, and low adaptive skills. She was eligible for special education and related services under the category of multiple disabilities based on her severe orthopedic impairment, intellectual disability, speech and language impairment, and visual impairment. At all relevant times, Student lived within the jurisdictional boundaries of District. 2. As a quadriplegic, Student was completely dependent upon others for her basic care and mobility. Student previously walked with a gait trainer, but as she grew into adulthood, her cerebral palsy caused severe spinal scoliosis, which left her wheelchair bound.
    [Show full text]
  • Best Practice for Gait Training
    PHARMACY & TECHNOLOGY The THERA-Trainer Complete Solution for Gait Rehabilitation Redesigning clinical treatment pathways for a best practice model for modern gait training Jakob Tiebel, Melanie Grom hat factors are particularly Neurological symptoms on the rise are becoming increasingly important important for successful in order to reduce the consequences W mobility rehabilitation fol- After decades of very little change in of neurological diseases and to achie- lowing a stroke? Which rehabilitation the healthcare system, in recent years ve the best possible reintegration into measures have been proven to improve change has become one of the only re- daily life, employment and society, balance, standing and walking ability? maining constants [30]. The structural whilst keeping costs at a reasonable le- What are the most likely strengths and developments of an ageing society, the vel [35]. Experts overwhelmingly agree what opportunities will there be for increase in chronic diseases and the that this requires thorough optimisati- rehabilitation facilities by being more onward march of medical and techno- on in terms of effectiveness, transpa- open to change? What are the current logical progress have led to fundamen- rency and economic efficiency in order weaknesses and what risks need to be tal changes in the requirements of re- to guarantee high-quality care, despite avoided? habilitation medicine. The shift in the the tough financial conditions [1]. morbidity spectrum towards chronic In particular, the use of quality-as- The restructuring taking place in the diseases means that neurological sym- surance evidence-based measures is German healthcare system over recent ptoms and syndromes, in particular, being discussed as a potential soluti- years has resulted in increasingly com- are on the increase.
    [Show full text]
  • Mucosal Delivery Systems of Antihypertensive Drugs: a Practical Approach in General Practice Lukasz P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2):71-78. Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice Lukasz P. Bialya,b, Cezary Wojcikc, Izabela Mlynarczuk-Bialya,b Patients who are unable to receive oral medication (p.o.) are a major problem in outpatient settings, especially in home health care systems. Mucosal administration of drugs offers an alternative to the oral route, especially when the parenteral mode cannot be used. There are three main pathways of mucosal administration: sublingual/buccal, intranasal and rectal. We discuss the possibility of mucosal delivery of antihypertensive drugs. Perindopril arginine and Amlodipine besylate are registered in the EU as orodispersible tablets for oromucosal delivery, however, they are not available in all countries. For this reason, we describe other drugs suitable for mucosal delivery: Captopril and Nitrendipine in the sublingual system and Metoprolol tartrate, Propranolol and Furosemide by the transrectal route. Based on the published data and common clinical practice we discuss the use of mucosal delivery systems of all these antihypertensive drugs with special attention to their pharmacokinetics. We illustrate this mini-review with a case report of the prolonged-term use of mucosal delivery of sublingual Captopril and Nitrendipine combined with rectal Metoprolol tartrate and Furosemide in a patient with severe hypertension unable to receive medication p.o. This is also a report on the first human use of Furosemide-containing suppositories as well as prolonged-term transmucosal administration of these four drugs, describing a practical approach leading to successful control of severe hyperten- sion with four antihypertensive drugs delivered via the mucosal route.
    [Show full text]
  • A Review on the Control of the Mechanical Properties of Ankle Foot Orthosis for Gait Assistance
    actuators Review A Review on the Control of the Mechanical Properties of Ankle Foot Orthosis for Gait Assistance Dimas Adiputra 1,2,† , Nurhazimah Nazmi 1,†, Irfan Bahiuddin 3,† , Ubaidillah Ubaidillah 4,†, Fitrian Imaduddin 4,†, Mohd Azizi Abdul Rahman 1,*,†, Saiful Amri Mazlan 1,† and Hairi Zamzuri 1 1 Advanced Vehicle System Laboratory, Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur 54100, Malaysia; [email protected] (D.A.); [email protected] (N.N.); [email protected] (S.A.M.); [email protected] (H.Z.) 2 Electrical Engineering Department, Institut Teknologi Telkom Surabaya, Surabaya 60234, Indonesia 3 Vocational School, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia; [email protected] 4 Mechanical Engineering Department, Universitas Sebelas Maret, Surakarta 57126, Indonesia; [email protected] (U.U.); fi[email protected] (F.I.) * Correspondence: [email protected] † These authors contributed equally to this work. Received: 20 December 2018; Accepted: 24 January 2019; Published: 28 January 2019 Abstract: In the past decade, advanced technologies in robotics have been explored to enhance the rehabilitation of post-stroke patients. Previous works have shown that gait assistance for post-stroke patients can be provided through the use of robotics technology in ancillary equipment, such as Ankle Foot Orthosis (AFO). An AFO is usually used to assist patients with spasticity or foot drop problems. There are several types of AFOs, depending on the flexibility of the joint, such as rigid, flexible rigid, and articulated AFOs. A rigid AFO has a fixed joint, and a flexible rigid AFO has a more flexible joint, while the articulated AFO has a freely rotating ankle joint, where the mechanical properties of the AFO are more controllable compared to the other two types of AFOs.
    [Show full text]
  • Educational Benefit Introductions
    Educational Benefit Introductions ALISON ROSE KIRSTIN COMSTOCK Program Coordinator, Program Coordinator, El Dorado Charter SELPA El Dorado Charter SELPA Training Objectives Participants will learn the following • Legal requirements and history • The definition of • Best practices for documenting student attainment surrounding educational benefit educational benefit of educational benefit and how to refine a student's IEP if the student is not attaining educational benefit • Legal responsibility for providing a full • Gain practical experience completing continuum of special education related an Ed. Benefit file review for a services and placement options student on their caseload A History of Legal Cases A Discussion of Educational Benefit Historical Context • The Rowley Decision • Endrew F. Decision • The Holland Factors Facts: • Eight year old student with a significant hearing impairment, but an excellent lip reader. The Rowley • IEP for first grade called for general Decision education placement with an FM system in the classroom, tutoring one hour per day, A Discussion of LRE and speech therapy 3 times per week. • Parents agreed with IEP, but wanted student to be provided with a sign- language interpreter. Findings: Meet the procedural requirements of the IDEA • IDEA does not require that the States maximize the potential of students with disabilities. • Instead- they must: The Rowley Decision A Discussion of LRE Meet the Be reasonably calculated to procedural provide requirements of educational the IDEA benefit State provides: *personalized
    [Show full text]
  • Diazepam Rectal Gel (Diastat) Administration
    LOS ANGELES UNIFIED SCHOOL DISTRICT Student Health and Human Services Division District Nursing Services DIAZEPAM RECTAL GEL (DIASTAT) ADMINISTRATION I. GENERAL GUIDELINES A. PURPOSE 1. To control acute, repetitive or prolonged seizures. 2. To prevent status epilepticus, a life-threatening condition in which seizures are continuous. 3. To administer Diastat safely and in a timely manner. B. GENERAL INFORMATION 1. Diazepam rectal gel (Diastat) is an “emergency anti-seizure medication” approved by Food and Drug Administration (FDA). Education Code 49414.7 allows unlicensed school staff to administer emergency anti-seizure medication to students with acute, prolonged or repetitive seizure 2. Licensed healthcare provider and parent authorizations for medication must be completed and signed. Healthcare Provider Authorization must specify student specific seizure symptoms, including frequency, type, duration, medication dosage, potential side effects and instructions when to call the paramedics. 3. Diastat training must be student specific- demonstration. Verbalization of the following by the trainee will occur upon completion of the training: a. Identification of characteristics of student’s seizures b. Understanding of Diastat order from the licensed healthcare provider c. Location, storage and disposal of Diastat d. Appropriate steps of administration of Diastat e. Care of the student before, during and after the administration of Diastat f. Documentation of Diastat administration 4. Parent/guardian must notify the school if Diastat was administered within the past 4 hours on a school day. C. PERSONNEL 1. School nurse or school physician 2. Designated school personnel who possess current First Aid and CPR Certification and are trained by the school nurse or the school physician.
    [Show full text]
  • Pediatric Gait Trainers, Standing Systems and Walkers
    UnitedHealthcare® Value & Balance Exchange Coverage Determination Guideline Pediatric Gait Trainers, Standing Systems and Walkers Guideline Number: IEX.CDG.101.02 Effective Date: May 1, 2021 Instructions for Use Table of Contents Page Related Policy Applicable States ........................................................................... 1 • Durable Medical Equipment, Orthotics, Medical Coverage Rationale ....................................................................... 1 Supplies and Repairs/Replacements Definitions ...................................................................................... 2 Applicable Codes .......................................................................... 3 Benefit Considerations .................................................................. 3 References ..................................................................................... 4 Guideline History/Revision Information ....................................... 4 Instructions for Use ....................................................................... 6 Applicable States This Coverage Determination Guideline only applies to the states of Arizona, Maryland, North Carolina, Oklahoma, Tennessee, Virginia, and Washington. Coverage Rationale See Benefit Considerations Indications for Coverage Walkers are proven and medically necessary in certain circumstances. For medical necessity clinical coverage criteria, refer to the InterQual® 2020, Oct. 2020 Release, Medicare: Durable Medical Equipment, Walkers. Click here to view the
    [Show full text]
  • Evidence-Informed Clinical Perspectives on Selecting Gait Trainer Features for Children with Cerebral Palsy
    Analysis Evidence-informed clinical perspectives on selecting gait trainer features for children with cerebral palsy Ginny Paleg, Roslyn Livingstone Background/Aims: Children with cerebral palsy often use gait trainers to augment their mobility. These are supportive walking devices that take the weight of the body through a solid or fabric ‘seat’, stabilise the trunk, and support the pelvis. The purpose of this analysis article is to review the evidence and clinical considerations influencing the selection of gait trainer features for children with cerebral palsy and to describe gait trainer models. Methods: A scoping methodology was used to identify any relevant research and clinical literature supporting the selection of different gait trainer features. An internet search was undertaken to identify a wide range of gait trainers currently available. Factors influencing the selection of different gait trainer features including frame and wheel style and support options are discussed, combining information from manufacturers’ websites, expert opinion and evidence from the literature review. Results: Twenty-seven articles were included in this study. These included nine intervention studies, three articles describing gait trainer development, three expert opinion articles, a survey of therapist opinion and a study comparing physical properties of three different gait trainers. In addition information on device features relevant to gait trainers was drawn from 10 intervention studies of children using hand-held walkers. Twenty-four different gait trainers were identified as being commercially available in the UK, Canada and USA at time of searching. Conclusions: Evidence supporting selection of gait trainer styles and features for children with cerebral palsy is very limited.
    [Show full text]
  • Recommending School-Based Physical Therapy Intervention Under IDEA Resource Manual
    Dosage Considerations: Recommending School-Based Physical Therapy Intervention Under IDEA Resource Manual Introduction Physical therapists (PTs) may provide services to students in educational settings under the Individuals with Disabilities Education Improvement Act (IDEA) of 2004.1 IDEA is a federal law requiring the provision of a free and appropriate public education for all children, regardless of disability. Part B of IDEA specifically mandates a free and appropriate education for children ages 3 to 21 who have a disability. Follow this link to the fact sheet on School-Based therapy: Providing Physical Therapy in Schools Under IDEA 2004.2 School-based PTs may evaluate students with disabilities to determine the need for services in the educational setting. As a related service to special education, physical therapy services for disabled students may be recommended to the individualized education program (IEP) team if the expertise of a PT is required for students to access the curriculum, if students participate in their education-al environment, and if students benefit from their specially designed educational program. School-based PTs may provide services to students in a variety of school settings such as the classroom, lunchroom, playground, gymnasium, or bathroom. Other environments may include work training sites and community settings for postsecondary transitions. In some cases, students who are medically fragile and are unable to attend school may receive physical therapy services as part of a home-based special education program when physical therapy is required to meet educational goals and objectives and/or support the student’s access to instruction. IDEA does not specify how the team determines the amount of physical therapy services to include in the IEP.
    [Show full text]
  • Intramuscular and Rectal Therapies of Acute Seizures
    Epilepsy & Behavior 49 (2015) 307–312 Contents lists available at ScienceDirect Epilepsy & Behavior journal homepage: www.elsevier.com/locate/yebeh Review Intramuscular and rectal therapies of acute seizures Ilo E. Leppik a,b,c,⁎,SimaI.Patelb,c a Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA b MINCEP Epilepsy Care, University of Minnesota Physicians, Minneapolis, MN, USA c Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA article info abstract Article history: The intramuscular (IM) and rectal routes are alternative routes of delivery for antiepileptic drugs (AEDs) Accepted 1 May 2015 when the intravenous route is not practical or possible. For treatment of acute seizures, the AED used should Available online 11 June 2015 have a short time to maximum concentration (Tmax). Some AEDs have preparations that may be given intramus- cularly. These include the benzodiazepines (diazepam, lorazepam, and midazolam) and others (fosphenytoin, le- Keywords: vetiracetam). Although phenytoin and valproate have parenteral preparations, these should not be given Intramuscular intramuscularly. A recent study of prehospital treatment of status epilepticus evaluated a midazolam (MDZ) Rectal Acute seizures autoinjector delivering IM drug compared to IV lorazepam (LZP). Seizures were absent on arrival to the emergen- Antiepileptic drugs cy department in 73.4% of the IM MDZ compared to a 63.4% response in LZP-treated subjects (p b 0.001 for supe- riority). Almost all AEDs have been evaluated for rectal administration as solutions, gels, and suppositories. In a placebo-controlled study, diazepam (DZP) was administered at home by caregivers in doses that ranged from 0.2 to 0.5 mg/kg.
    [Show full text]
  • Hypotonic Delivery of Drugs and Drug-Loaded Nanoparticles to the Gastrointestinal Tract
    HYPOTONIC DELIVERY OF DRUGS AND DRUG-LOADED NANOPARTICLES TO THE GASTROINTESTINAL TRACT By Katharina Maisel A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland December, 2014 © 2014 Katharina Maisel All Rights Reserved ABSTRACT Innovative gastrointestinal (GI) drug delivery vehicles such as mucus penetrating nanoparticles (MPP) and fluid-absorption inducing (hypotonic) delivery vehicles have potential to improve therapeutic outcomes over conventional methods such as mucoadhesive particles (MAP) for GI diseases, including ulcerative colitis (UC) and HIV pre-exposure prophylaxis (PrEP). More than 80% of all drugs are absorbed via the GI tract for either systemic or local treatment. MAP delivered to the GI tract are thought to improve oral absorption or local targeting of difficult-to-deliver drug classes. Mucus is a continuously secreted barrier that effectively traps foreign particulates to protect the underlying epithelium. Rapid clearance of the most superficial luminal mucus layers in the GI tract may limit the effectiveness of MAP. Here, I test the current dogma of mucoadhesion by comparing MAP and MPP GI drug delivery via the oral and rectal routes. In addition I investigate the development of several vehicles including rectal enemas and gels for more effective delivery of nanocarriers or free drugs. First, I illustrate that MPP uniformly coat all surfaces of the GI epithelium, while MAP aggregated in mucus in the center of the lumen, far away from the absorptive epithelium, both in healthy mice and mice with UC. In the mouse colorectum, MPP penetrated into mucus in the deeply in-folded surfaces to evenly coat the entire epithelial surface.
    [Show full text]